Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cost Control: Obama Advocates For More Powerful MedPAC

This article was originally published in The Gray Sheet

Executive Summary

A proposal to establish an executive-branch commission with authority to set Medicare payment rates and enact reimbursement reforms gained steam in the past week in response to high-profile advocacy from President Obama

You may also be interested in...



House Health Reform Amendments Round-Up: AAA Screening Report, No IMAC

Amendments to ban reduced payments for pain treatments and make screenings for aneurysms a priority are just two provisions added to a health reform bill during the House Energy and Commerce Committee's marathon mark-up sessions July 30 and 31

House Health Reform Amendments Round-Up: AAA Screening Report, No IMAC

Amendments to ban reduced payments for pain treatments and make screenings for aneurysms a priority are just two provisions added to a health reform bill during the House Energy and Commerce Committee's marathon mark-up sessions July 30 and 31

Bill Would Have New Agency Set Medicare Reimbursement Rates

Legislation introduced by Sen. Jay Rockefeller, D-W.Va., would convert the Medicare Payment Advisory Commission into an executive branch agency responsible for determining payment rates for items and services furnished under Medicare

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027702

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel